Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Dominik Linz , William McIntyre Added: 1 year ago
In this video from the Arrhythmia Academy’s Journal Club, Dr Dominik Linz (Maastricht University Medical Centre, Maastricht, NL) is joined by Dr William McIntyre (McMaster University, Hamilton, CA) to discuss a paper published in Europace 2022 titled “Estimated incidence of previously undetected atrial fibrillation on a 14-day continuous electrocardiographic monitor and associated risk of stroke”… View more
Job title: Interventional Cardiologist
DrColm Hanratty is anInterventional Cardiologist atMater Private Hospital, Dublin, IE. Prior to joining Mater Private Hospital,he was clinical lead within the Belfast Trust for 8 years. He has sub-specialty interest in the management of complex Percutaneous Coronary Intervention (PCI) and is internationally recognised as one of the leading interventionists in terms of complex and chronic total… View more
Job title: University of Witwatersrand Johannesburg, South Africa, Consultant Vascular Surgeon Professor of Venous Surgery
Prof Stephen Black is a Consultant Vascular Surgeon at Guy’s and St Thomas’ Hospital and a Professor of Venous Surgery at Kings College, London. He is the Site Lead for Surgery at Guy’s and St Thomas’ Hospital and the Co-R&D Lead for the Cardiovascular Directorate (Cardiology, Cardio-Thoracic and Vascular Surgery). He was Clinical Lead for Vascular Surgery for 4 years (2019-2023).Dr Black is the… View more
Author(s): Jaber Abboud , Joachim R Ehrlich Added: 3 years ago
Implantable cardioverter defibrillators (ICDs) have been used for over 30 years to prevent sudden cardiac death (SCD). The first indications for ICD placement were secondary prevention; later trials demonstrated a primary prevention benefit of ICD therapy in patients at risk of SCD. ICD therapy prolongs life in both patient populations.1 However, the efficacy of an ICD depends on its ability to… View more
Author(s): Pok Tin Tang , Duc H Do , Anthony C Li , et al Added: 3 years ago
Ventricular arrhythmias remain a major contributor to cardiac morbidity and mortality worldwide, despite ongoing research and implementation of novel therapeutic interventions. Modern management of patients with ventricular arrhythmias requires a multidisciplinary team approach, especially in complex presentations with a background of multiple medical comorbidities.1,2 Such teams may include… View more
Author(s): Roderick Tung , Gaurav A Upadhyay Added: 3 years ago
In 1970, Durrer et al. recorded the total excitation of the human heart with 870 electrodes and confirmed the first 10 ms of left ventricular (LV) activation as trifascicular in nature.1 The rapid and synchronous activation of the LV through the specialised His–Purkinje network is highly intricate and efficient, preserving normal physiological coupling between electrical excitation and mechanical… View more
Author(s): Line Melgaard Added: 5 years ago
Dr Line Melgaard (Aalborg University, Aalborg, DK) discusses the thromboembolic risk in patients with atrial fibrillation and valvular heart disease according to the EHRA Type 2 definition. Filmed on site at EHRA 2019 by Radcliffe Cardiology Questions: 1. What was the need to evaluate atrial fibrillation patients specifically with valvular heart disease? 2. How was the study set up to… View more
Author(s): Pavel Osmancik Added: 4 years ago
Dr Pavel Osmancik (University Hospital Kralovske Vinohrady, Prague, CZ) discuses 'Long-term follow-up of the PRAGUE-12 study and the five-year outcomes in cardiac surgery patients with atrial fibrillation undergoing concomitant surgical ablation versus no ablation' at HRS 2019. 1. Can you tell us about the Prague-12 Study and why was it initiated? 2. What is the design of the trial? 3. What are… View more
Dr Nicholas Inston graduated in medicine from the University of Nottingham with a BMedSci awarded in 1991 and BM BS in 1993. His first post was in the Professorial Dept of Surgery at QMC, Nottingham and thereafter as Anatomy Demonstrator at Nottingham University, surgical training on the Warwickshire and Worcestershire rotation and higher surgical training in the West Midlands Deanery. Developing… View more
Author(s): Jagmeet P Singh Added: 2 years ago
In this interview, Dr Jagmeet Singh (Massachusetts General Hospital, Harvard Medical School, Boston, MA, US) discusses the Phase I results of the Solve-CRT Study presented at ESC's Heart Rhythm Society event in 2021. This study is a multicenter pivotal trial, investigating the safety of the WiSE CRT System in leadless cardiac resynchronization therapy. Questions: 1. Could you briefly remind us… View more